Intestinal metaplasia (IM) is a pre-malignant condition of the gastric mucosa associated with
increased gastric cancer (GC) risk. We performed (epi) genomic profiling of 138 IMs from …

Intestinal metaplasia (IM) is a pre-malignant condition of the gastric mucosa associated with
increased gastric cancer (GC) risk. Analyzing 1,256 gastric samples (1,152 IMs) across 692 …

Intestinal metaplasia (IM) is a premalignant lesion associated with gastric cancer (GC) but is
poorly described in terms of molecular changes. Here, we explored the role of TP53, a …

Intestinal metaplasia in the esophagus (Barrett's esophagus IM, or BE-IM) and stomach
(GIM) are considered precursors for esophageal and gastric adenocarcinoma, respectively …

Gastric cancer is the third leading cause of cancer-related mortality and the fifth most
common cancer globally. An estimated 1 million new cases and 750,000 related deaths are …

Gastric cancer remains the third leading cause of cancer-related mortality and the fifth most
common cancer worldwide, responsible for an estimated 1 million new cases and more than …

Background: Gastric cancer (GC) is one of the leading causes of cancer-related deaths
worldwide. GC is a pathologically and molecularly heterogeneous disease. DNA …

Gastric intestinal metaplasia is a precancerous change of the mucosa of the stomach with
intestinal epithelium, and is associated with an increased risk of dysplasia and cancer. The …

Evidence suggests that Helicobacter pylori plays a role in gastric cancer (GC) initiation.
However, epidemiologic studies on the specific role of other bacteria in the development of …

Gastric cancer remains the third leading cause of cancer-related mortality and the fifth most
common cancer worldwide. 1 There is marked global variation of disease with areas of high …